Bifidobacterium Bifidum Oral Capsule — Competitive Intelligence Brief

Bifidobacterium Bifidum Oral Capsule (Bifidobacterium Bifidum Oral Capsule) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Probiotic. Area: Gastroenterology.

marketed Probiotic Gastroenterology Small molecule

Target snapshot

Bifidobacterium Bifidum Oral Capsule (Bifidobacterium Bifidum Oral Capsule) — The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. Bifidobacterium bifidum is a live probiotic bacterium that colonizes the gut microbiota and promotes beneficial microbial balance.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Bifidobacterium Bifidum Oral Capsule TARGET	Bifidobacterium Bifidum Oral Capsule	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	marketed	Probiotic
E. coli Nissle suspension	E. coli Nissle suspension	University of Hohenheim	marketed	Live biotherapeutic product (probiotic)
Mixture of three Bifidobacteria	Mixture of three Bifidobacteria	Federico II University	marketed	Probiotic
Lactobacillus Fermentum	Lactobacillus Fermentum	HEM Pharma Inc.	marketed	Live biotherapeutic / Probiotic
Synbiotic 2000	Synbiotic 2000	Beth Israel Medical Center	marketed	Synbiotic (prebiotic + probiotic combination)
L. reuteri Prodentis® lozenges	L. reuteri Prodentis® lozenges	University of Zagreb	marketed	Probiotic
Clotrimazole vaginal tablets+ Lactobacillus	Clotrimazole vaginal tablets+ Lactobacillus	Peking University Shenzhen Hospital	marketed	Antifungal + probiotic combination	Fungal lanosterol 14α-demethylase (CYP51); Lactobacillus competitive exclusion and microbiota restoration

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Probiotic class)

1. BioBalance Corporation · 1 drug in this class
2. Biocodex · 1 drug in this class
3. CD Pharma India Pvt. Ltd. · 1 drug in this class
4. CHU de Quebec-Universite Laval · 1 drug in this class
5. Chuncheon Sacred Heart Hospital · 1 drug in this class
6. Dow University of Health Sciences · 1 drug in this class
7. Federico II University · 1 drug in this class
8. Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan · 1 drug in this class
9. GWT-TUD GmbH · 1 drug in this class
10. Aga Khan University · 1 drug in this class